thumbnail.png

Are you offering non-invasive prenatal testing (NIPT) to all pregnant women?

Recent bulletins and guidelines from ACMG, ACOG, ISPD, and ASHG/ESHG recommend a discussion of NIPT with all patients (both high risk and average risk) at their first prenatal visit. Are you having the conversation? We have compiled key resources for you to use when expanding your genetic testing offering to all women.

1.

NIPT is Strongly Validated.

More than 68,613 patients < 35 years of age at gestation have been evaluated in 8 studies to provide further clarity around the clinical benefits of prenatal testing.


SEE DETAILS > 

2.

NIPT is Supported by Guidelines.

The American Congress of Obstetrics & Gynecologists, among other societies, now acknowledges the use of NIPT for all singleton pregnancies, regardless of age or risk.

READ MORE >

3.

NIPT is Widely Covered.

31 commercial health plans, comprised of roughly 92 million covered lives, have revised their medical policy to include NIPT for all singleton pregnancies.


LEARN MORE >

4.

NIPT is Well Supported.

Natera provides a variety of complementary tools to patients and physicians to assist when further information is needed at any stage of the NIPT testing process, from pre- and post-test genetic counseling, test cost estimator, and more.

SEE HOW >

More Questions? Call 1-844-528-3390


Share with Colleague 

NIPT is Strongly Validated
Hub_Medicalpolicy-397x265.jpg

Rigorous Average Risk NIPT Studies

Since 2012, over 68,613 average risk patients have been evaluated in 8 studies. These studies have provided further clarity around the benefits and economical impact of prenatal testing for your patients.

Review Study Data

Panorama validated in high risk and average risk cohorts

Similar performance in both patient cohorts

Panorama is validated in both high and average risk cohorts and demonstrates similar positive predictive value (PPV both >80%

See PPV Data

NIPT is Guideline Recommended
Society guidelines endorsing NIPT for all women

Endorsed by Society Guidelines

The use of NIPT for all women is now acknowledged by major societies including American Obstetrics & Gynecologists (ACOG), American College of Medical Genetics and Genomics (ACMG), International Society for Prenatal Diagnosis (ISPD), and more.

View Guideline Statements

ACMG guidelines supporting NIPT

Latest ACMG Statement

ACMG released a statement supporting the use of noninvasive prenatal tests (NIPT/NIPS) as an optimal, initial option to screen for specific genetic conditions, such as Trisomy 21, during pregnancy for all women, regardless of maternal age.

View ACMG Announcement

NIPT is Widely Covered
Changes for NIPT in medical policy

Increasing Insurance Coverage

NIPT is considered medically necessary as a primary screening test for all women carrying singleton pregnancies by several health plans, including Anthem Blue Cross.

Coverage Overview

Health plans in-network with Natera

View All In-Network Plans

Panorama is pleased to be an in-network provider with many health plans, including Aetna, Anthem, Cigna and United Healthcare.

See In-network Plans

Natera's test cost estimator

Estimate Test Cost

Help your patients estimate the cost of their Panorama prenatal screen with the Test Cost Estimator.

Try Test Cost Estimator

NIPT is Well Supported
Genetic counseling sessions from Natera

Genetic Information Session

Whether it is educating a patient prior to testing or explaining results afterward, Natera's board-certified genetic counselors are here to help. Schedule these complimentary one-on-one sessions pre- and post- test!

Watch Video

Panorama patient algorithm for genetic testing

Patient Algorithm

During a pregnancy, there are multiple testing options that can provide patients with additional information about potential genetic conditions in their baby. Download the Prenatal Testing Algorithm from Natera including a list of potential screening tests for your patients.

View Diagram

Natera's Patient Portal

More resources on Patient Portal

Through their journey from learning about screening tests to taking and tracking the test, accessing resources to answer questions, and sharing their experience with us.

Log In to Portal